| Literature DB >> 32392892 |
Wiktoria Tomal1, Joanna Ortyl1,2.
Abstract
Light-initiated polymerization processes are currently an important tool in various industrial fields. The advancement of technology has resulted in the use of photopolymerization in various biomedical applications, such as the production of 3D hydrogel structures, the encapsulation of cells, and in drug delivery systems. The use of photopolymerization processes requires an appropriate initiating system that, in biomedical applications, must meet additional criteria such as high water solubility, non-toxicity to cells, and compatibility with visible low-power light sources. This article is a literature review on those compounds that act as photoinitiators of photopolymerization processes in biomedical applications. The division of initiators according to the method of photoinitiation was described and the related mechanisms were discussed. Examples from each group of photoinitiators are presented, and their benefits, limitations, and applications are outlined.Entities:
Keywords: biomedical applications; cationic photopolymerization; free-radical photopolymerization; photopolymerization; two-photon initiators (2PP); type I photoinitiators; type II photoinitiators; water-soluble photoinitiators
Year: 2020 PMID: 32392892 PMCID: PMC7285382 DOI: 10.3390/polym12051073
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Examples of light-induced polymerization processes in biomedical applications.
Figure 2Number of published articles in the years 1970–2019.
Figure 3Highlights of initiators’ requirements.
Figure 4The photo initiation process using: A. type I initiator, B. type II initiator.
Figure 5Initiation in multi-component systems: D – electron donor, A – electron acceptor.
Figure 6Schematic mechanism of initiation using two-photon photoinitiators.
Figure 7Various initiators from the Irgacure family used in biomedical applications.
Figure 8Commonly used monomers for preparing hydrogel materials by a photoinitiated polymerization reaction.
Figure 9Monoacylphosphine oxide (MAPO) and bisacylphosphine oxide (BAPO) water-soluble derivatives.
Comparison of spectroscopic properties, solubility, and toxicity of water-soluble monoacylphosphine oxide (MAPO) and bisacylphosphine oxide (BAPO) derivatives [142].
| Initiator | Derivative of | Spectroscopic Properties | Solubility | Toxicity | |
|---|---|---|---|---|---|
| λmax-ab | ε @λmax-ab | ||||
| LAP | MAPO | 380.5 | 191 | 47 | 3.1 |
| TPO-Na | MAPO | 380.5 | 250 | 29 | < 0.56 |
| BAPO-OLi | BAPO | 383.5 | 197 | 54 | 2.6 |
| Bapo-ONa | BAPO | 383.5 | 256 | 60 | 2.8 |
LC50 – determines cytotoxicity in the cell culture. LC50 corresponds to the concentration of a given medium, which is fatal for 50% of cells.
Summary of the main water-soluble initiators used in biomedical applications, their basic properties, and photo induced cleavage of photoinitiators.
| Type of Initiator | Name of Initiator | Structure, Together with a Simplified Scheme | Maximum Absorbance / Source of Irradiation | Key Strengths | Key Drawbacks | Ref. |
|---|---|---|---|---|---|---|
| Type I |
|
| 276 nm/ | High initiation rate, low cytotoxicity, and immune- | Low initiation efficiency, need for UV light sources, low water solubility (<5 w.%) | [ |
| Type I |
|
| 267, 298, | Cleaves into highly reactive radicals, good thermal stability | Poor water solubility | [ |
| Type I |
|
| 375 nm/ | Good water solubility, possibility of using UV and visible light sources | Low initiation efficiency, especially when exposed to light from the visible range | [ |
| Type I |
|
| 375 nm/ | Good water solubility | Very low extinction coefficient in the range above | [ |
| Type I |
|
| 365 nm/ | Low toxicity, providing 90% cell survival, high initiation rate, good water solubility | Released nitrogen causes bubble formation | [ |
| Type II |
|
| 528 nm/ | Good water solubility, low cytotoxicity, wide range of absorbance, possibility to use different light sources in visible range, possibility to use low light powers | A second ingredient is needed for high initiation efficiency – the co-initiator | [ |
| Type II |
|
| 444 nm/ | Wide absorption range based on the visible range | Modification needed to increase solubility in water, strongly yellow after reaction | [ |
| Type II |
|
| 223, 267, 373 and 444 nm / | Excellent water solubility, wide absorption range, also in the visible area, non-toxic, beneficial to cells | Possibility of creating reactive oxygen species | [ |
| 2PP |
|
| source of irradiation: laser – 800 nm | very good water solubility, excellent optical sensitivity, and resolution, no toxicity | significant limitations of speed fabrication | [ |
| 2PP |
|
| [ | |||
| 2PP |
|
| [ |
Figure 10Type II initiators used in biomedical applications.
Figure 11Comparison of one-photon and two-photon polymerizations.
Figure 12Dyes used in the two-photon polymerization process.
Figure 13Examples of two-photon initiators used in biomedical applications.
Figure 14Water-soluble, new initiators containing sodium salt of propionic acid.
Figure 15β-cyclodextrin structure and inclusion complexes of the host-guest type with photoinitiators; (A): β-cyclodextrin, (B): thioxanthone and β-cyclodextrin, (C): benzophenone and β-cyclodextrin, (D): 2,2-dimethoxy-2-phenyl acetophenone and β-cyclodextrin.
Figure 16The structures of widely used additives in multi-component initiating systems for biomedical applications.